Medicare Enrolled

Dr. Mohammad Abbas, M.D.

Pain Medicine · Leesburg, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Mixed engagement
1801 US HIGHWAY 441 BLDG 100, Leesburg, FL 34748
3524604004
In practice since 2016 (9 years)
NPI: 1669826921 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abbas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abbas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abbas

Dr. Mohammad Abbas is a pain medicine specialist in Leesburg, FL, with 9 years of NPI registration. Based on federal Medicare data, Dr. Abbas performed 2,323 Medicare services across 787 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abbas received a total of $4,604 from 9 pharmaceutical and/or device companies across 32 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abbas is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ Top 47% volume in FL $4,604 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,323
Medicare services
Top 47% in FL for pain medicine
787
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~258 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
527 $0 $5
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
412 $0 $5
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
369 $100 $195
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
289 $1 $5
Contrast dye for imaging, lower concentration 168 $0 $5
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
154 $130 $255
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
78 $126 $250
Betamethasone steroid injection
An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate.
78 $5 $15
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
46 $199 $370
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
36 $74 $145
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
33 $0 $10
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
32 $89 $175
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
31 $139 $265
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
31 $72 $135
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
28 $51 $100
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
11 $61 $110
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,604
Total received (2019-2024)
Avg $921/year across 5 years
Top 33% in FL for pain medicine
9
Companies
32
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$1,771 (38.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,626 (35.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,206 (26.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$330
2023
$401
2022
$500
2021
$3,268
2019
$104

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$2,498
Pinnacle, Inc
$1,206
Abbott Laboratories
$585
Allergan Inc.
$104
AbbVie Inc.
$97
ABBVIE INC.
$43
Boston Scientific Corporation
$35
AstraZeneca Pharmaceuticals LP
$21
Teva Pharmaceuticals USA, Inc.
$15
Top 3 companies account for 93.2% of total payments
Associated products mentioned in payments ›
AJOVY · BOTOX · INTELLIS ADAPTIVESTIM · KYPHON EXPRESS II KYPHOPAK TRAY · PROCLAIM · PRODIGY · PROPEL · Proclaim IPG · SYNCHROMEDII · UBRELVY · Vanta · WATCHMAN FLX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (38%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work.

Equivalent to $198 per 100 Medicare services performed
Looking for a pain medicine specialist in Leesburg?
Compare pain medicines in the Leesburg area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
5
Per 100K population
1.3
County median income
$69,956
Nearest hospital
UF HEALTH LEESBURG HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Abbas is a clinical cardiology specialist, with moderate Medicare volume, with mixed engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Abbas experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Abbas performed 527 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abbas receive payments from pharmaceutical companies?
Yes. Dr. Abbas received a total of $4,604 from 9 companies across 32 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abbas's costs compare to other pain medicines in Leesburg?
Dr. Abbas's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abbas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →